| pubmed-article:9522940 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C0042036 | lld:lifeskim |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C0001622 | lld:lifeskim |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C0026256 | lld:lifeskim |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:9522940 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:9522940 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9522940 | pubmed:dateCreated | 1998-5-8 | lld:pubmed |
| pubmed-article:9522940 | pubmed:abstractText | To determine whether the urine cortisol-to-creatinine ratio (UCCR) could replace the ACTH stimulation test in monitoring effectiveness of mitotane induction treatment in dogs with pituitary-dependent hyperadrenocorticism (PDH). | lld:pubmed |
| pubmed-article:9522940 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9522940 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9522940 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9522940 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9522940 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9522940 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9522940 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9522940 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9522940 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9522940 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9522940 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9522940 | pubmed:issn | 0002-9645 | lld:pubmed |
| pubmed-article:9522940 | pubmed:author | pubmed-author:GrahamPP | lld:pubmed |
| pubmed-article:9522940 | pubmed:author | pubmed-author:NachreinerR... | lld:pubmed |
| pubmed-article:9522940 | pubmed:author | pubmed-author:CenterS ASA | lld:pubmed |
| pubmed-article:9522940 | pubmed:author | pubmed-author:ScarlettJ MJM | lld:pubmed |
| pubmed-article:9522940 | pubmed:author | pubmed-author:RandolphJ FJF | lld:pubmed |
| pubmed-article:9522940 | pubmed:author | pubmed-author:ReimersTT | lld:pubmed |
| pubmed-article:9522940 | pubmed:author | pubmed-author:ToomeyJJ | lld:pubmed |
| pubmed-article:9522940 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9522940 | pubmed:volume | 59 | lld:pubmed |
| pubmed-article:9522940 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9522940 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9522940 | pubmed:pagination | 258-61 | lld:pubmed |
| pubmed-article:9522940 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:meshHeading | pubmed-meshheading:9522940-... | lld:pubmed |
| pubmed-article:9522940 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9522940 | pubmed:articleTitle | Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD). | lld:pubmed |
| pubmed-article:9522940 | pubmed:affiliation | Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. | lld:pubmed |
| pubmed-article:9522940 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9522940 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
